In rodents exposed to 3,3 ¶-iminodipropionitrile (IDPN), neurofilaments (NFs) accumulate in swollen proximal axon segments; this also occurs in motor neurons of patients with amyotrophic lateral sclerosis. We hypothesized that early loss of NFs in neuromuscular junctions (NMJs) in IDPN proximal neuropathy would result in neuromuscular dysfunction and lead to neuromuscular detachment. Adult male rats were given 0 or 15 mmol/L IDPN in drinking water for up to 1 year. The IDPNexposed rats dragged their tails and had impaired endurance in a grip test. Neuromuscular junctions and distal axons were examined in the levator auris longus muscle after 3, 6, 9, and 12 months. Neuromuscular junctions showed a progressive reduction in NF immunolabeling, which became undetectable in up to 70% of the NMJs after 12 months. Neurofilament labeling was also reduced in preterminal axons and in a more proximal axon level within the muscle. Triple-label analysis with antisyntaxin demonstrated that the terminals remained in place and usually contained a few minute NF bundles. Electron microscopy revealed the disappearance of terminal NFs, reduced content in synaptic vesicles, and accumulation of multilamellar bodies, but scant degeneration. Thus, IDPN proximal neurofilamentous axonopathy is associated with NF depletion in motor terminals; motor weakness and structural changes in the NMJs suggest impaired synaptic function despite long-term preservation of the NMJs.
INTRODUCTION
Neurofilaments (NFs) are the intermediate filaments of neurons and are critical in determining axonal diameter.
Abnormal accumulations of NFs occur in many nervous system diseases. For example, in amyotrophic lateral sclerosis (ALS), NF-filled swellings are frequently found in proximal axon segments of motor neurons (1) . In laboratory rodents, strikingly similar accumulations of NFs occur in the proximal segments of large-caliber myelinated axons after exposure to 3,3 ¶-iminodipropionitrile (IDPN) (2) . Griffin et al (3) demonstrated that this is associated with impaired slow axonal transport, which is responsible for the proximodistal displacement of NFs. However, the mechanism by which IDPN causes this impairment remains unidentified. 3,3 ¶-Iminodipropionitrile toxicity has been studied as a model for understanding the pathogenesis of ALS (3Y5), but 2 major difficulties have been found. First, exposure to high doses of IDPN causes a permanent syndrome of abnormal hyperactive behavior, which is not easy to relate to ALS (6, 7) . We now know that this behavior results from the toxic action of IDPN on the vestibular system (8Y11). This may be unrelated to the axonal effect because there are other nitriles that cause vestibular degeneration (12, 13) but no axonal swelling (14) . Second, chronic low-dose IDPN exposure caused axonal swelling, but no subsequent motor neuron degeneration was found (15) . This and subsequent studies used a low-dose regimen (0.05% in the drinking water); however, there is evidence that significant degeneration may be triggered by exposure to higher doses (16) .
Accumulating evidence supports the notion that ALS is likely to be a distal axonopathy in which retraction of the terminals is a major factor in motor neuron degeneration (17Y25). Consequently, it would be interesting to identify the pathologic features that are present in the motor terminals in association with the proximal swellings, a question for which IDPN provides a potentially useful experimental model. However, apart from an early observation (26) , the behavior of NFs has only recently been examined at the most distal parts of motor neurons affected by IDPN proximal neurofilamentous axonopathy (27) . Using a model for chronic IDPN exposure, we observed a rapid (5 weeks of exposure) significant loss of NF content within the neuromuscular junction (NMJ). In this study, we examined the long-term consequences of IDPN-induced impairment in axonal transport on motor performance, the associated changes in terminal and preterminal NF content, and the structural appearance of the NMJ. We hypothesized that the loss of NFs would be associated with significant neuromuscular dysfunction and may lead to overt pathology. Although many studies have found no significant neuromuscular degeneration after chronic IDPN exposure (15) , our dose was similar to that used in a study that recorded significant degeneration of this kind (16) . In rats exposed to IDPN for up to 1 year, we demonstrate an accelerated decline in motor performance, a marked loss of neurofilaments in the motor terminals, and limited evidence of pathologic alterations of the NMJ. 
MATERIALS AND METHODS

Chemicals and Reagents
Animals
The care and use of animals were in accordance with Law 5/1995 and Act 214/1997 of the Autonomous Community (Generalitat) of Catalonia and approved by the University of Barcelona's Ethics Committee on Animal Experiments. Male Long-Evans rats (aged 8Y9 weeks) were obtained from Janvier (Le-Genest-Saint-Isle, France). They were housed 2 per cage in standard Macrolon cages (280 Â 520 Â 145 mm) at 22-C T 2-C, with wood shavings as bedding. At least 7 days were allowed for acclimation before experimentation. The rats were maintained on a 12:12 light-dark cycle (0700:1900 hours) and given standard diet pellets (TEKLAD 2014; Harlan Interfauna Ibérica, Sant Feliu de Codines, Spain) ad libitum. For immunohistochemistry, the rats were anesthetized with 400 mg/kg chloral hydrate and transcardially perfused with 50 mL of heparinized saline, followed by 350 mL of 4% paraformaldehyde in 0.1 mol/L PBS, pH 7.4. For electron microscopy, the rats were anesthetized with ketamine and xylazine. Then, 1.5 mL of TRITC-BTX (1:500 in PBS) were injected subcutaneously in the dorsal neck region, above the anatomic localization of the levator auris longus (LAL) muscles, 30 minutes before killing the animal for tissue sampling. The dorsal neck region tissues including the LAL were immersed in 2.5% glutaraldehyde in PBS for fixation during dissection under a fume hood.
Experimental Design
Rats were exposed to 0 (controls) or 15 mmol/L of IDPN in drinking water for 3, 6, 9, or 12 months. The concentration of IDPN was selected to be maximal without causing vestibular hair cell degeneration (28, 29) , an effect associated with a syndrome of abnormal spontaneous motor behavior of vestibular origin (9, 10) . The animals were weighed weekly and examined for motor function at different times during the treatment. The holding time on a vertical ladder was assessed at approximately 2-week intervals up to day 298, and gait analysis was performed monthly up to 11 months. During the experiment, the treated animals were observed to drag their tails, so quantitative assessment of tail dragging was performed at days 277, 311, 340, and 359 of exposure. A second batch of animals, initially planned for histologic analysis only, was also used to assess tail dragging up to 6 months of exposure. In addition, all the animals were assessed for vestibular dysfunction at monthly intervals. At 3, 6, 9, and 12 months of exposure, 2 to 4 IDPN animals were killed as previously described for immunohistochemistry of the LAL muscle. One control rat was processed along with 1 to 3 treated rats in each experimental batch. Muscles were stored at j20-C in cryoprotective solution (34.5% glycerol, 30% ethylene glycol, 20% PBS, 15.5% distilled water) until immunolabeling. At the same time points, 1 control and 3 treated animals were killed and processed for electron microscopy assessment of the NMJs in the LAL muscle.
Behavioral Analysis Holding Time on a Vertical Ladder
The endurance of the rats holding on to a vertical ladder was measured as previously described (30) . Briefly, a parallel bar grid used as a ladder was vertically placed inside the acrylic tube of a hot plate test apparatus (Model-DS37; Ugo Basile, Comerio, Varese, Italy) and covered with a board to prevent the rat from escaping. The hot plate temperature was set at 56-C. Before IDPN exposure, the animals were trained to avoid the hot plate by holding on to the vertical ladder for up to 120 seconds. On the test days, rats were allowed to escape after 120 seconds or when they had climbed up the ladder for the third time after 2 shorter holding episodes. The mean holding time of these 2 episodes, or the maximal 120-second time, was recorded for each animal.
Gait Topography Analysis
Stepping movements were evaluated as described by Parker and Clarke (31) . First, we marked the rat's hind feet and forefeet with ink (red and black ink, respectively). Then, the rat walked across chart paper on an elevated pathway, leaving a permanent record of its footprints. Stride length and stride width were then measured.
Tail Drag Analysis
We used the same procedure as in the gait analysis to quantitatively measure tail dragging, except that the tail was inked instead of the paws. The total length of the marks left by the tail on the chart paper was measured.
Vestibular Dysfunction Assessment
To evaluate the effect of IDPN exposure on vestibular function, we used a previously described test battery (30) . The battery includes an observation of spontaneous motor behavior, as well as assessment of the tail-hang reflex, contact inhibition of the righting reflex, and the air-righting reflex (10) .
Immunohistochemistry Protocol and Analysis
Double and triple immunofluorescence and confocal analyses were performed on the LAL muscles. Although the LAL has been shown to include 2 subpopulations of motor neurons with different susceptibility to degeneration in a mouse model of spinal muscular atrophy (32) , the corresponding rostral and caudal parts of this muscle were not evaluated separately in the present (rat) study. Whole mounts of LAL were immunolabeled as free-floating specimens in accordance with previously published standard protocols (33) . Briefly, muscles were rinsed with PBS and then incubated with 4% bovine serum albumin and 1% Triton X-100 in PBS. They were processed to detect the NFs and postsynaptic nicotinic acetylcholine receptors (AChRs) simultaneously or to detect NFs with syntaxin and AChRs. Muscles were incubated overnight with primary antibodies for 24 hours at 4-C (1:1000). The specimens were then incubated overnight at 4-C with the Alexa Fluor or TRITC secondary antibodies (1:300 to 1:500) in 4% bovine serum albumin and 0.5% Triton X-100 in PBS that also contained TRITC-BTX (1:400) to label the postsynaptic AChRs. After the final washes, the muscles were mounted in Mowiol mounting medium (34) .
A TCS-SL confocal microscope (Leica Microsystems CMS GmbH, Mannheim, Germany) was used for quantitative analysis of the specimens processed by double labeling of NFs and AChRs. Observations were performed using the same conditions for all the samples. As many representative images as possible were obtained from each sample and then stored for further observation and analysis. Quantitative data were obtained by analysis of the stored images using MacBiophotonics ImageJ software (National Institutes of Health, Bethesda, MD). For these analyses, we assessed 3 different regions on the motor neuron (i.e. the NMJ region, the most distal [preterminal] axonal region, and a more proximal location within the main nerve tract supplying the muscle) as described in the next paragraphs. A more detailed description has been published (27) .
For NMJ assessment, we first delimited the area of study on each image that was suitable for analysis, and the amount of TRITC-BTX fluorescence was recorded. We then classified each terminal as either containing NF labeling or no visible labeling in the area defined by BTX. For this category measure, the percentage of NF-containing terminals was determined for each animal and the animal was the unit for statistics. Next, we obtained the amount of NF fluorescence in the NMJ region, which was then expressed as a percentage of TRITC-BTX fluorescence. Individual NMJs were the units used for statistical analysis, and only the junctions containing visible NF label were included.
To determine the axonal NF content in the most distal (preterminal) segment of the axon, we delimited a square area placed tangentially to the area labeled by TRITC-BTX and determined the amount of fluorescence in this area. Axons were the units for comparisons between treatment groups (27) . To determine axonal NF content in a more proximal location, fluorescence measures were performed on the nerve tract supplying the muscle. For group comparisons, a single value of fluorescence intensity was obtained for each animal by averaging the values obtained in several replicates (images).
Observation of specimens with triple labeling was performed in a Nikon TE2000-E confocal microscope (Nikon, Amstelveen, The Netherlands). We determined the percentage of NMJs with syntaxin labeling in the area defined by BTX labeling.
Transmission Electron Microscopy
The LALs were fixed with 2.5% glutaraldehyde in PBS for 1.5 to 2 hours and rinsed briefly with PBS. The region of each muscle that contained the NMJs was identified by fluorescence microscopy of the TRITC-BTX label resulting from the in vivo injection, and the muscles were trimmed accordingly. The specimens were then fixed for 2 hours with 1% osmium tetroxide, dehydrated with increasing concentrations of ethanol up to 100%, and embedded in Epon resin. Semithin sections (1 Km thick) were stained with 1% toluidine blue and examined in a light microscope to localize the NMJs. Ultrathin sections were then obtained, stained with uranyl acetate and lead citrate, and observed with a JEOL 1010 transmission electron microscope at 75 to 80 kV.
Statistical Analysis
Body weight data were analyzed using repeated-measures analysis of variance (ANOVA) (Greenhouse-Geisser correction) because multivariate ANOVA (MANOVA) was not possible due to insufficient degrees of freedom. Vertical ladder data were analyzed using the Mann-Whitney U test because this test includes a maximal escape latency of 120 seconds, which is obtained by most animals early in the experiment. Other behavioral data were tested with repeated-measures MANOVA (Wilks crierion), with day as the within-subject factor. The Student t-test was used for day-by-day comparisons if a significant day Â treatment interaction was found. Histologic data were analyzed using one-way ANOVA, followed by Dunnett test when applicable. The > level was set at 0.05. Analyses were performed using the SPSS 16.0 for Windows program package.
RESULTS
Both control rats and rats exposed to 15 mmol/L of IDPN in drinking water gained weight during the treatment period, and a significant day effect was recorded (F 2.2,19.4 = 176.2, p G 0.001) (Fig. 1) . The weight increase was smaller in the IDPN group versus the control group, resulting in statistically significant differences in the effects of treatment (F 1,9 = 23.9, p G 0.001) and day Â treatment interaction (F 2.2,19.4 = 21.1, p G 0.001). Group mean body weights were similar until significant differences occurred at Day 58 of exposure; they remained significantly different for the rest of the experiment. Whereas the weight of control rats increased up to 692.8 T 14.2 g at 350 days of treatment (which represents 235% of the initial body weight), treated rats reached only 481.9 T 19.8 g (162% of the initial body weight).
In the vertical ladder test, both control and treated rats showed a decline in performance with time, but there were markedly different time courses (Fig. 2) . Control rats showed optimal performance for 5 months and a progressive decline from 5 to 10 months of the experiment (at age 8Y13 months). Increasing body weight ( Fig. 1 ) and age likely account for this loss in performance in controls. The performance of the rats exposed to IDPN began to decline by 2 months of exposure and was significantly worse ( p G 0.05) than that of control rats at most evaluation times, up to the last time of evaluation at 300 days of exposure. Because of the progressive decline in the performance of control rats, the vertical ladder test was not performed beyond this time point. The faster decline in performance in treated rats was not caused by a larger demand of the task in this group because the animals had to bear their own weight; indeed, treated rats had lower body weights than control rats (Fig. 1) .
There was progressive alteration in the walking prints of treated rats that indicated a decline in motor performance. Quantitative analysis of gait parameters from the footprints revealed no effect of IDPN up to Day 336 because both control and IDPN-exposed rats showed similar stride length and similar forelimb and hindlimb stride width (Fig. 3) . Observation of animals walking and the resulting prints indicated that the footprints were altered because they were swept by the animal's tail, which was often dragging. This conclusion was supported by the direct recording of tail prints (Fig. 4) . Tail print records were obtained from Day 277 in the batch of animals used for the behavioral analysis and between Days 30 and 181 in a second batch of animals initially intended for histologic study only. The data revealed that tail dragging started by 4 months of exposure and was conspicuous during the period from 9 to 12 months of exposure.
In the assessment of vestibular dysfunction, control-like ratings, consisting of values of 0 to 2, were found up to 4 months of IDPN exposure. Starting at 5 months of exposure, some animals showed moderate evidence of vestibular dysfunction, which affected up to 8 of 18 animals in the group after further exposure. After 8 months of exposure, most of these animals still had low ratings of vestibular dysfunction (3Y6 on a scale of 24); only 3 of the exposed animals had moderate ratings (8Y12). Comparison of the vestibular data with the vertical ladder data (Fig. 5 ) and the tail drag data (not shown) revealed no significant correlations (p 9 0.05). When a significant decline in performance in the vertical ladder was already established in the treated group at 3 months of exposure, these animals still showed no vestibular dysfunction (Fig. 5A) . When vestibular dysfunction was first observed at 5 months, the affected animals were not the ones that had the worst performance in the vertical ladder (Fig. 5B) . Finally, no relationship was observed between the 2 measures for treated animals at 8 months, although control animals showed both intact vestibular function and better holding performance (Fig. 5C ).
As expected, IDPN exposure caused NF accumulation in the proximal axon regions, which was seen as axonal balloons with high NF immunoreactivity in the spinal cord of the treated animals (data not shown). In contrast, a reduction in NF immunoreactivity was observed at the 3 distal levels examined in detail: NMJs, preterminal axons, and bundle axons. In the NMJs, there was an obvious decrease in NF labeling (Fig. 6) . Double immunohistochemistry showed an apparent complete loss of NF labeling in many NMJs. In control LAL muscle (Fig. 6AaYc) . The NF mark showed a branched pattern distributed with the mature AChR pattern (yellow in overlay image and arrows). After exposure to IDPN for 6 ( Fig. 6Ad-f ), 9 (Fig. 6AgYi), or 12 (Fig. 6AjYl) months, the intensity of the NF labeling decreased. The synapses had fewer NF branches in the AChR area (arrows in Fig. 6Af, i) ; in some endplates, the NF label was absent (Fig. 6Af, i, l; asterisks) . The percentage of junctions containing a visible NF label in control animals (mean value, 97.6, n = 5 rats; data from 186 junctions) was progressively reduced by IDPN exposure ( Fig. 6B ; F 4,12 = 39, p G 0.001) to the point that only a mean of 28.9% of the junctions identified by BTX labeling displayed a visible NF label at 12 months of exposure (n = 4, data from 345 junctions). Figure 6Al shows AChR areas (red and asterisk) without NF staining. Intermediate reductions in percentage values were recorded at 3 (n = 3; 189 junctions), 6 (n = 2; 214 junctions), and 9 (n = 3; 489 junctions) months of exposure. In addition, the junctions with a visible NF label had a reduced anti-NF label, expressed as the percentage of fluorescence, with respect to TRITC-BTX fluorescence in the same junction ( Fig. 6C ; F 4,334 = 34.7, p G 0.001).
3,3 ¶-Iminodipropionitrile caused a reduction in fluorescence intensity of the AChR labeling by TRITC-BTX (F 4,345 = 4.25, p = 0.002). This effect was not progressive, and similar decreases in comparison with control values were observed at 3 (23%), 9 (26%), and 12 (21%) months of exposure.
3,3 ¶-Iminodipropionitrile exposure also caused a reduction in NF immunoreactivity in both the preterminal axon ( Fig. 7A;  F 4 ,519 = 124, p G 0.001) and in a more proximal region of the axon at the level of the main nerve bundle within the muscle ( Fig. 7B; F 4 ,12 = 5.92, p = 0.007).
Triple label analysis revealed that the loss of NF label observed in the previous analysis did not correspond with retraction of the nerve terminals from the muscle contacts because the syntaxin label was maintained (Fig. 8) . The percentage of junctions with syntaxin in control animals (mean value, 100; n = 2 rats; data from 47 junctions) was not significantly altered by IDPN at 3 (100%, n = 2, 94 junctions), 6 (100%, n = 2, 69 junctions), 9 (97%, n = 2, 189 junctions), and 12 (98%, n = 2, 128 junctions) months of exposure. In addition, this series revealed that most of the junctions classed as containing no visible NF labels in the previous series did in fact contain very thin and short NF processes ( Fig. 8 ; see panel with 2 arrows).
Ultrastructural analysis of NMJs from control animals showed standard features, including a high density of synaptic vesicles and well-formed postsynaptic foldings (Fig. 9A) , the presence of NFs within the neuromuscular ending (Fig. 9B) , and high densities of regularly spaced NFs in the myelinated preterminal axon (Fig. 9C) . In animals exposed to IDPN for 6 to 12 months, common findings included low densities of synaptic vesicles (Fig. 9D, E, G, H) , accumulations of mitochondria (Fig. 9G) , and multilamellar bodies (Fig. 9G, H) in the NMJ. In addition, preterminal axons in these animals often had lower densities of NFs (Fig. 9F) , and there were high densities of microtubules with an apparent lack of NFs in some cases (Fig. 9I) . A few autophagy figures were observed in the terminals of one of the animals exposed for 6 months, but these and other evidence of degeneration were not a common finding.
DISCUSSION
The accumulation of NFs that occurs in the proximal axon segments of rodents exposed chronically to IDPN has been well described (2, 15, 35) , and its similarity to that found in ALS has been clearly recognized (1) . This proximal axonopathy is known to be associated with reduced axonal diameter at locations distal to the swelling (3), but the behavior of NFs in the distal axonal end during this proximal axonopathy has not yet been fully characterized. In a recent study, we quantified the NF content in the distal motor axon regions, including the NMJ area, the preterminal axon, and a slightly more proximal location at the level of the axon bundle that supplies rat LAL, that is, the muscle under study. We demonstrated that a rapid decrease in NF content occurs in the NMJ area, with a 50% reduction by 5 weeks of exposure to IDPN through drinking water (27) . These data did not prove or reject the hypothesis being tested, which was that a net retrograde transport of NFs might contribute to the proximal swellings in the IDPN axonopathy. However, they indicated that the NMJ is significantly altered early in this model. Therefore, this model might help elucidate the link between proximal NF accumulation and NMJ dysfunction, an issue that remains unresolved in ALS. In the present study, we evaluated the chronic (up to 1 year) effects of this intoxication paradigm on behavior and NMJ morphology. The results indicated that the distal loss of NFs is aggravated by continuous exposure to the axonopathic agent and that this effect is associated with behavioral dysfunction and altered the ultrastructure of the NMJ, including reduced content in synaptic vesicles and the accumulation of multilamellar bodies.
Compared with controls, IDPN-treated rats showed an accelerated decline in motor performance. Significantly reduced holding times in the vertical ladder test were an early effect of the IDPN treatment. On the ladder, the rat has to hold its own weight with its grip to avoid the hot plate. Reduced performance in control rats was observed at later times of the experiment, as the animals became older and gained weight. In IDPN animals, the initial reduction in holding times was approximately coincident with the initial group differences in body weight. Although IDPN-exposed rats developed lower body weights and therefore had to make less effort, their performance was reduced. Another change in motor function was observed in the IDPN-treated animals in the evaluation of walking patterns. Stride parameters did not change, but the animals progressively modified their body position during walking. In particular, striking differences were observed in the position of the tail, which the rats dragged with increasing frequency as the treatment progressed. We obtained a quantitative evaluation of this effect by recording ''tail-prints,'' and this measure seems to provide an easy and sensitive measure of tail drop. Tail position and holding times have been recognized as sensitive measures of motor dysfunction in genetic rodent models of ALS. For example, holding times in an inverted grid test, which probably involved similar motor requirements to those in our vertical ladder test in rats, were considerably reduced in Tardbp +/j mice despite normal walking stride parameters (36) . In addition, reduced tail elevation was found as an early motor effect in SOD1 G93A mice, well before changes in stride parameters were recorded (37) . Further work is necessary to ascertain whether the alterations in behavior recorded in this study do in fact reflect deficits in neuromuscular function.
One potential confounder of the present behavioral results is the interference of vestibular dysfunction, which profoundly alters motor behavior (10, 30) . The IDPN concentration in this study was selected to cause no vestibular dysfunction, and no evidence of vestibular dysfunction was recorded for several weeks (27) . However, after 5 months of exposure, some animals started to show signs of vestibular dysfunction, and this effect may have interfered with the behavioral assessment of motor deficits. Some evidence suggested that vestibular dysfunction was not the cause of the recorded deficits in motor performance. First, the observed vestibular dysfunction was small to moderate and appeared only after the motor performance deficits were evident. Second, overt vestibular dysfunction causes an increase in stride width (30) , which was not recorded in this study. Third, there was no clear association between vestibular dysfunction and motor performance because animals with no vestibular deficits showed significant behavioral alterations in the vertical ladder test and tail dragging. Fourth, overt axonal degeneration and muscular atrophy have been associated with behavioral deficits that indicate muscle weakness in a similar chronic IDPN model (16) . We concluded that an indirect effect of IDPN on the holding times and tail prints cannot be completely excluded, but that IDPN rats probably started suffering a certain degree of muscle weakness by 2 months of exposure. Nevertheless, future studies using IDPN to model motor neuron diseases may preferably choose a smaller concentration to avoid the interference of vestibular dysfunction.
A number of previous studies are available on the consequences of long-term exposure to IDPN through drinking water. Clark et al (15) reported axonal atrophy in sciatic nerve regions distal to the proximal zones, along with axonal swellings in rats drinking 0.05% IDPN. In the same model, demyelination, intramyelinic vacuoles, Schwann cell ingrowths into axons, and onion bulb formation were documented in the proximal axon, but no overt axonal degeneration was found and the NMJs were not examined (38, 39) . Kitahara et al (16) used a higher concentration of IDPN (0.13%) and found axonal degeneration and neurogenic muscle atrophy. Although our concentration was higher (0.18%), we obtained less clear evidence of neuromuscular degeneration. Because we used Long-Evans rats and Kitahara et al (16) used Sprague-Dawley rats, straindependent differences in the dose-response relationship may account for the difference. In our previous 5-week analysis, we observed a 50% reduction in NF immunoreactivity in NMJs of IDPN-exposed rats, but this did not include significant reductions in the percentage of junctions, defined by BTX labeling, which apparently showed a complete loss of NF signal (27) . In the present study, using the same methodology, a ''complete absence'' of NF labeling was recorded in an increasing proportion of NMJs: from 37% at 3 months of IDPN to 71% at 12 months. In the junctions that retained noticeable NF labeling, the remaining label was lower than in control junctions. Although an apparent increase from 6 months was found at 9 months for this parameter, it must be remembered that it excludes the junctions with apparent complete absence of NFs, which indicated a greater effect at the later time point. Taken together, the present and previous (27) data demonstrate a progressive loss of NFs in the NMJ, evolving to virtually complete absence. Nevertheless, detailed analysis revealed the enduring presence of a few NFs even in the most depleted junctions. More importantly, the major drop in NF labeling did not denote withdrawal of the presynaptic terminals from the muscle, as demonstrated by the persistent syntaxin label in the confocal images and the preserved structure of the nerve terminal in the electron microscopy images. One conclusion that can be obtained from these data is that a dramatic loss in presynaptic NF labeling does not necessarily indicate that the presynaptic element has degenerated. As discussed later, this conclusion is relevant when we interpret the results of studies in which NF immunoreactivity is used as the sole or main label to mark the presynaptic motor neuron terminal (24) .
In the preterminal and axon bundle regions, NF content, as defined by immunolabeling, was also markedly reduced, although this reduction became evident as thinning and fragmentation of the axonal NF mark, and not as disappearance of the axon. This is consistent with the existence of a stable NF cytoskeleton being slowly deconstructed during the IDPN axonopathy (40) . The ultrastructural observations confirmed that many neuromuscular terminals were still in place but contained no visible NFs. They also provided limited but significant evidence for pathologic alterations in the neuromuscular endings. Although autophagy and other degeneration features were not prominent, changes such as a lack of NFs, decreased densities of synaptic vesicles, and accumulation of multilamellar bodies suggest that pathologic alterations and physiologic deficits developed in the NMJ in association with the development of the proximal NFfilled swellings that characterize IDPN axonopathy before overt degeneration. Neurofilaments have been shown to coorganize with synaptic vesicle clusters in terminals, and this relationship is altered in the mutated survival motor neuron mouse model (41) . It is thus possible that NF alterations modify synaptic vesicle dynamics and that this contributes to altered neurotransmission and perhaps to final terminal retraction. The observation of a significant but not progressive decrease in AChR labeling in the NMJs from treated animals also supports the conclusion that IDPN alters neurotransmission; this may be an early effect because it was already observed after 3 months of exposure.
A marked decrease in NF labeling has been recently described in limb muscles of ALS patients (21) . This finding has been interpreted as denoting denervation, but it may be caused, at least partly, by depletion of NF content in preserved terminals. In fact, published electron microscopy images of NMJs from ALS patients reveal a lack of NFs in terminals that are nevertheless in contact with the postsynaptic foldings (42) . If we compare this with published experimental data, the long-term maintenance of NMJs in the absence of NFs found in the present study is in agreement with the reported viability and absence of prominent axonal degeneration in a strain of transgenic mice in which NFs are retained in the perikaryal region and not transported down the axon (43) . Nevertheless, these same mice have recently been shown to suffer impaired regeneration after nerve damage (44) ; thus, NF absence may indeed have delayed pathologic consequences despite its compatibility with initial endurance, as also suggested by the present data.
3,3 ¶-Iminodipropionitrile impairs the slow axonal transport of NFs by an as yet unknown mechanism, resulting in proximal axonopathy (3). This axonopathy was initially studied as a model for ALS because of the similarity of the proximal NF accumulations it induces with those observed in motor neurons of ALS patients (1) . The present data indicate that chronic IDPN exposure also results in a dramatic loss of NFs, reduced synaptic vesicle content, and multilamellar body accumulation in the NMJs, in association with early appearing changes in motor performance. Future work should establish the hypothesized causality of these observations and the possible contribution of the NF effects to NMJ dysfunction. The chronic IDPN model may be interesting for the initial phases of neuromuscular diseases and allow us to address these questions. In addition, IDPN seems to be a useful experimental tool to study the interaction between environmental (toxic) and genetic (mutation) causes of motor neuron degeneration.
